doi: 10.1016/S0140-6736(09)61375-1 90 LeanMEJCarraroRFinerNHartvigHLindegaardMLRssnerSet al
A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia
Currently, the core registration studies to assess the efficacy of retatrutide include: TRIUMPH-1 : A randomized, double-blind, placebo-controlled trial to test the safety and effectiveness of a treatment for people with obesity or overweight, including those with OSA and OA, but without type 2 diabetes
GLP-1 medications do not directly cause vitamin deficiencies in everyone, but they can make them more likely over time by lowering appetite and reducing overall food intake
Fabi is also an assistant clinical professor at the University of California, San Diego
Managing injection site reactions Redness, swelling, or itching at the injection site affects a subset of patients